PL3377071T3 - Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami - Google Patents

Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami

Info

Publication number
PL3377071T3
PL3377071T3 PL16865816.9T PL16865816T PL3377071T3 PL 3377071 T3 PL3377071 T3 PL 3377071T3 PL 16865816 T PL16865816 T PL 16865816T PL 3377071 T3 PL3377071 T3 PL 3377071T3
Authority
PL
Poland
Prior art keywords
human milk
milk oligosaccharides
associated complications
antibiotic associated
treating antibiotic
Prior art date
Application number
PL16865816.9T
Other languages
English (en)
Inventor
Bruce Mcconnell
Louise Kristine VIGSNÆS
David Paul KRONLAGE
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL3377071T3 publication Critical patent/PL3377071T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL16865816.9T 2015-11-17 2016-11-17 Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami PL3377071T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562256170P 2015-11-17 2015-11-17
US201662299186P 2016-02-24 2016-02-24
US201662345959P 2016-06-06 2016-06-06
PCT/DK2016/050371 WO2017084673A1 (en) 2015-11-17 2016-11-17 Synthetic Composition for Treating Antibiotic Associated Complications

Publications (1)

Publication Number Publication Date
PL3377071T3 true PL3377071T3 (pl) 2024-06-24

Family

ID=58717396

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16865816.9T PL3377071T3 (pl) 2015-11-17 2016-11-17 Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami

Country Status (6)

Country Link
US (2) US10864224B2 (pl)
EP (1) EP3377071B1 (pl)
CN (1) CN108348536B (pl)
ES (1) ES2975018T3 (pl)
PL (1) PL3377071T3 (pl)
WO (1) WO2017084673A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) * 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
PL3377071T3 (pl) * 2015-11-17 2024-06-24 Glycom A/S Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami
PL3452050T3 (pl) * 2016-05-05 2023-06-12 Glycom A/S Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
MX2018015725A (es) 2016-07-01 2019-09-09 Evolve Biosystems Inc Método para facilitar la maduración del sistema inmunitario de mamíferos.
US12233079B2 (en) 2018-12-19 2025-02-25 Glycom A/S Composition and method for treating humans using low-fodmap diets
KR20220101131A (ko) * 2019-11-14 2022-07-19 글리콤 에이/에스 장내 담즙산 프로필의 균형을 맞추기 위한 합성 조성물
US20220395542A1 (en) * 2019-11-20 2022-12-15 Abbott Laboratories Nutritional Compositions for Treating a Clostridium Difficile Infection
CN118924795A (zh) * 2019-11-29 2024-11-12 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
DK202430092A1 (en) 2024-02-23 2025-08-29 Dsm Ip Assets Bv Hmo mixture and its use in reducing c. difficile toxins
CN120570904A (zh) * 2025-07-14 2025-09-02 苏州一兮生物技术有限公司 一种用于预防和/或治疗腹泻的组合物及其用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
AU2007222375B2 (en) 2006-03-09 2012-12-20 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
CN101420966B (zh) 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途
US8197872B2 (en) * 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
EP2222310B1 (en) 2007-10-11 2016-08-03 Promovita ingredients limited Preparation for treating intestinal infection comprising oligosaccharides and insoluble cellular material
US20110009359A1 (en) 2007-12-21 2011-01-13 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota
JP2012510476A (ja) 2008-12-02 2012-05-10 プロラクタ バイオサイエンス，インコーポレイテッド ヒト乳透過組成物ならびにその製造および使用方法
KR101218893B1 (ko) 2009-03-05 2013-01-09 닛산 지도우샤 가부시키가이샤 쌍극형 2차 전지 및 그 제조 방법
CA2758097A1 (en) 2009-04-07 2010-10-14 Glycom A/S Synthesis of 2'-o-fucosyllactose
EP3241836B1 (en) 2010-02-19 2024-10-30 Glycom A/S Polymorph of a tetrasaccharide containing nacetyl-lactosamine
US9200091B2 (en) * 2010-07-12 2015-12-01 The Regents Of The University Of California Bovine milk oligosaccharides
MY191538A (en) * 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
CN103429604A (zh) 2011-02-21 2013-12-04 格礼卡姆股份公司 寡糖前体的混合物的组合物的催化氢解及其用途
AU2012232727A1 (en) 2011-03-18 2013-09-26 Glycom A/S Synthesis of new fucose-containing carbohydrate derivatives
KR20140036227A (ko) 2011-05-13 2014-03-25 글리콤 에이/에스 모유 올리고사카라이드(hmo) 또는 그의 전구체의 생성 방법
US20140323705A1 (en) 2011-05-13 2014-10-30 Markus Hederos Manufacture of lacto-n-tetraose
EP2707379A4 (en) * 2011-05-13 2014-10-08 Glycosyn LLC USE OF PURIFIED 2'-FUCOSYLLACTOSIS, 3-FUCOSYLLACTOSIS AND LACTODIFUCOTETRAOSE AS PREBIOTICS
EP2522232A1 (en) 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
CA2835989A1 (en) 2011-05-13 2012-11-22 Glycom A/S Diversification of human milk oligosaccharides (hmos) or precursors thereof
CA2846603A1 (en) * 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN103958537A (zh) 2011-09-30 2014-07-30 格礼卡姆股份公司 Hmo核心结构的合成
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
US20150065702A1 (en) 2012-03-20 2015-03-05 Glycom A/S Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof
EP2836218A4 (en) * 2012-04-13 2015-10-21 Trustees Boston College PROBIOTIC COMPOSITIONS AND METHODS OF USE
US9902984B2 (en) 2013-09-06 2018-02-27 Glycom A/S Fermentative production of oligosaccharides
WO2015032413A1 (en) 2013-09-06 2015-03-12 Glycom A/S Fermentative production of oligosaccharides
EP3082827A1 (en) * 2013-11-15 2016-10-26 Nestec S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
US10695358B2 (en) 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
SG11201608248YA (en) * 2014-04-08 2016-10-28 Abbott Lab Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
PL3377071T3 (pl) * 2015-11-17 2024-06-24 Glycom A/S Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami

Also Published As

Publication number Publication date
WO2017084673A1 (en) 2017-05-26
US11998558B2 (en) 2024-06-04
CN108348536A (zh) 2018-07-31
EP3377071B1 (en) 2024-01-10
US20210100822A1 (en) 2021-04-08
ES2975018T3 (es) 2024-07-02
EP3377071A1 (en) 2018-09-26
US10864224B2 (en) 2020-12-15
CN108348536B (zh) 2021-09-24
EP3377071A4 (en) 2019-08-14
US20180325929A1 (en) 2018-11-15

Similar Documents

Publication Publication Date Title
SG11202000900SA (en) Microorganism for producing human milk oligosaccharide
EP3332717A4 (en) TREATMENT DEVICE
EP3265053A4 (en) Methods for treating skin
EP3280375A4 (en) Body massaging apparatus
EP3153104A4 (en) Medical treatment system
SG11201700621XA (en) Antibiotic compositions for treating bacterial infections
CA3290062A1 (en) System for treating unwanted tissue
ZA201804628B (en) Treatment fluid preparation system
EP3095378A4 (en) Medical treatment system
EP3263152A4 (en) Medical treatment device
EP3720446A4 (en) HUMAN MILK OLIGOSACCHARIDES FOR THE TREATMENT OF MIGRAINE
EP3316693A4 (en) A process for treating milk
PL3253395T3 (pl) Preparat probiotyczny do leczenia zapalenia jelit
GB201514303D0 (en) Bifidobacteria for treating cardiac conditions
GB201604658D0 (en) Treatment for pain
IL256236B (en) Mannose derivatives for the treatment of bacterial infections
PL3518801T3 (pl) Układ do leczenia chirurgicznego
EP3285764A4 (en) Methods for treating cryptosporidiosis using triazolopyridazines
SG11202004923XA (en) Sterilization method
GB201718985D0 (en) Treatment
EP3323368A4 (en) TREATMENT TOOL
GB201522536D0 (en) Processes for making milk and milk-related products
IL249616A0 (en) Methods for treating inflammation
ZA201805215B (en) Preparation for nasal-nasopharyngeal treatment
ZA202001317B (en) Pasteurizer